These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17330412)

  • 1. [Neck pain and fever after peginterferon alpha-2a].
    Moser C; Furrer J; Ruggieri F
    Praxis (Bern 1994); 2007 Feb; 96(6):205-7. PubMed ID: 17330412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fever of unknown origin (FUO): de Quervain's subacute thyroiditis with highly elevated ferritin levels mimicking temporal arteritis (TA).
    Cunha BA; Chak A; Strollo S
    Heart Lung; 2010; 39(1):73-7. PubMed ID: 20109988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peginterferon alph-2b (Sylatron) for melanoma.
    Med Lett Drugs Ther; 2011 Sep; 53(1373):76. PubMed ID: 21921873
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas.
    Loquai C; Nashan D; Hensen P; Luger TA; Grabbe S; Sunderkötter C; Schiller M
    Eur J Dermatol; 2008; 18(1):29-35. PubMed ID: 18086586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [De Quervain thyroiditis. Corner points of the diagnosis].
    Oláh R; Hajós P; Soós Z; Winkler G
    Orv Hetil; 2014 Apr; 155(17):676-80. PubMed ID: 24755450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon alfa-2a in patients with chronic hepatitis C.
    Zeuzem S; Feinman SV; Rasenack J; Heathcote EJ; Lai MY; Gane E; O'Grady J; Reichen J; Diago M; Lin A; Hoffman J; Brunda MJ
    N Engl J Med; 2000 Dec; 343(23):1666-72. PubMed ID: 11106715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient.
    Borrás-Blasco J; Primo J; Rosique-Robles JD; Casterá E; Abad FJ; Jiménez I
    South Med J; 2008 Jan; 101(1):88-90. PubMed ID: 18176299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.
    Heathcote EJ; Shiffman ML; Cooksley WG; Dusheiko GM; Lee SS; Balart L; Reindollar R; Reddy RK; Wright TL; Lin A; Hoffman J; De Pamphilis J
    N Engl J Med; 2000 Dec; 343(23):1673-80. PubMed ID: 11106716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
    Rustgi VK; Esposito S; Hamzeh FM; Shiffman ML
    Aliment Pharmacol Ther; 2008 Mar; 27(5):433-40. PubMed ID: 18081737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma.
    Dummer R; Garbe C; Thompson JA; Eggermont AM; Yoo K; Maier T; Bergstrom B
    J Clin Oncol; 2006 Mar; 24(7):1188-94. PubMed ID: 16505439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute thyroiditis (de Quervain's) due to influenza A: presenting as fever of unknown origin (FUO).
    Cunha BA; Berbari N
    Heart Lung; 2013; 42(1):77-8. PubMed ID: 22819125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute thyroiditis manifesting as fever of unknown origin.
    Weiss BM; Hepburn MJ; Mong DP
    South Med J; 2000 Sep; 93(9):926-9. PubMed ID: 11005359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotoxicosis with pegylated interferon alfa-2b.
    Lowndes SA; Asher R; Middleton MR
    Arch Dermatol; 2010 Nov; 146(11):1273-5. PubMed ID: 21079065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
    Lau GK; Piratvisuth T; Luo KX; Marcellin P; Thongsawat S; Cooksley G; Gane E; Fried MW; Chow WC; Paik SW; Chang WY; Berg T; Flisiak R; McCloud P; Pluck N;
    N Engl J Med; 2005 Jun; 352(26):2682-95. PubMed ID: 15987917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
    Marcellin P; Lau GK; Bonino F; Farci P; Hadziyannis S; Jin R; Lu ZM; Piratvisuth T; Germanidis G; Yurdaydin C; Diago M; Gurel S; Lai MY; Button P; Pluck N;
    N Engl J Med; 2004 Sep; 351(12):1206-17. PubMed ID: 15371578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Quervain's subacute thyroiditis presenting as a painless solitary thyroid nodule.
    Bianda T; Schmid C
    Postgrad Med J; 1998 Oct; 74(876):602-3. PubMed ID: 10211354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C.
    Falaschi P; Martocchia A; D'Urso R; Proietti A
    J Endocrinol Invest; 1997 Jan; 20(1):24-8. PubMed ID: 9075068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin.
    Berg C; Goncales FL; Bernstein DE; Sette H; Rasenack J; Diago M; Jensen DM; Graham P; Cooksley G
    J Viral Hepat; 2006 Jul; 13(7):435-40. PubMed ID: 16792536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials.
    Chalasani N; Manzarbeitia C; Ferenci P; Vogel W; Fontana RJ; Voigt M; Riely C; Martin P; Teperman L; Jiao J; Lopez-Talavera JC;
    Hepatology; 2005 Feb; 41(2):289-98. PubMed ID: 15660392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.